Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Inventory (2016 - 2025)

Avanos Medical's Inventory history spans 8 years, with the latest figure at $132.3 million for Q4 2022.

  • For Q4 2022, Inventory fell 16.95% year-over-year to $132.3 million; the TTM value through Dec 2022 reached $132.3 million, down 16.95%, while the annual FY2022 figure was $132.3 million, 16.95% down from the prior year.
  • Inventory for Q4 2022 was $132.3 million at Avanos Medical, down from $157.6 million in the prior quarter.
  • Across five years, Inventory topped out at $168.9 million in Q4 2020 and bottomed at $121.4 million in Q4 2018.
  • The 5-year median for Inventory is $145.9 million (2019), against an average of $145.0 million.
  • The largest annual shift saw Inventory skyrocketed 33.26% in 2018 before it dropped 16.95% in 2022.
  • A 5-year view of Inventory shows it stood at $121.4 million in 2018, then rose by 20.18% to $145.9 million in 2019, then increased by 15.76% to $168.9 million in 2020, then decreased by 5.68% to $159.3 million in 2021, then dropped by 16.95% to $132.3 million in 2022.
  • Per Business Quant, the three most recent readings for AVNS's Inventory are $132.3 million (Q4 2022), $157.6 million (Q1 2022), and $159.3 million (Q4 2021).